Eckard

Eckard discovered numerous violations, including a contaminated water system and an air system that allowed for cross-contamination between different products being made there.

GlaxoSmithKline Settles Drug Case For $750M By DENISE LAVOIE 2010

In 2004, a former quality-assurance manager at Glaxo, Cheryl Eckard, filed a lawsuit against the company in federal court in Boston, alleging that the company submitted false claims to government health programs because drugs manufactured at the Puerto Rico plant weren't safe and effective, and thus shouldn't have been covered by government programs.

Glaxo to Pay $750 Million in Pact; Whistleblower Due Big Payment Peter Loftus 2010

As a whistleblower under the federal False Claims Act, Eckard will receive $96 million of the settlement paid by the company.

GlaxoSmithKline Settles Drug Case For $750M By DENISE LAVOIE 2010

Eckard, who worked at the company's offices in North Carolina, said she was fired in 2003 after repeatedly reporting the problems to the company.

GlaxoSmithKline Settles Drug Case For $750M By DENISE LAVOIE 2010

Eckard eventually went to the Food and Drug Administration to report the problems and later filed a whistleblower lawsuit.

GlaxoSmithKline Settles Drug Case For $750M By DENISE LAVOIE 2010

Steven Eckard, Cheryl's ex-husband, said, I can tell you as a quality-assurance auditor she was very good at her job.

Whistleblower's Long Journey Peter Loftus 2010

"This is not something I wanted to do, but because of patient safety it was necessary," Eckard, 51, told reporters following a Justice Department news conference in Boston.

GlaxoSmithKline settles defective-drug lawsuit for $750 million Justin Blum 2010

Glaxo and the U.S. Justice Department announced the accord Tuesday, resolving a lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company.

GlaxoSmithKline settles defective-drug lawsuit for $750 million Justin Blum 2010

In 2002, drug maker GlaxoSmithKline PLC sent one of its quality-assurance managers, Cheryl Eckard, to Puerto Rico to help clean up a mess at one of its biggest manufacturing plants.

Whistleblower's Long Journey Peter Loftus 2010

The investigation began after Cheryl Eckard, the company's global quality assurance manager, went to the Puerto Rico plant in August 2002 to lead a team of scientists and quality experts to correct manufacturing violations cited by the FDA.

GlaxoSmithKline Settles Drug Case For $750M By DENISE LAVOIE 2010